A comprehensive review of the taxonomy, pathogenesis, and therapeutic challenges of Malassezia pachydermatis in companion animals
DOI:
https://doi.org/10.24425/pjvs.2026.3615Abstract
Malassezia pachydermatis is a lipophilic yeast that forms part of the skin microbiota of dogs and cats, and can transform into an opportunistic pathogen when the microbial equilibrium is disrupted. It is most commonly implicated in cases of otitis externa and dermatitis in dogs, and is increasingly isolated from cats as well, particularly in instances of otitis externa. The rising number of infections reported in recent years underscores the growing significance of this microorganism in veterinary medicine. Despite its clinical relevance, standardized methods for assessing the antifungal susceptibility of M. pachydermatis are still lacking. Existing studies vary in the culture used, incubation conditions, and interpretation of minimum inhibitory concentration (MIC) values, which complicates the comparison of results and the evaluation of the true extent of antifungal resistance. Of particular concern is the increasing resistance to azoles, which remain the cornerstone of therapy for Malassezia-associated infections. Due to the limitations in efficacy and safety of conventional antifungal drugs, natural compounds with antifungal activity, including essential oils, are receiving increasing attention. These oils are mixtures of volatile plant metabolites with a broad spectrum of biological activity, including antibacterial, anti-inflammatory, and antifungal properties. Selected essential oils, such as oregano and thyme oils, have been shown to exhibit significant activity against yeasts of the genus Malassezia. Their potential therapeutic application represents a promising research direction, particularly in the context of increasing resistance to conventional antifungal agents.
References
Ahmad A, Khan A, Manzoor N (2013) Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. Eur J Pharm Sci 48: 80-86.
Åhman S, Perrins N, Bond R (2007) Carriage of Malassezia spp. yeasts in healthy and seborrhoeic Devon Rex cats. Med Mycol 45: 449-455.
Åhman SE, Bergström KE (2009) Cutaneous carriage of Malassezia species in healthy and seborrhoeic Sphynx cats and a comparison to carriage in Devon Rex cats. J Feline Med Surg 11: 970-976.
Álvarez-Pérez S, García ME, Peláez T, Blanco JL (2016) Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort? Med Mycol 54: 72-79.
Bajwa J (2017) Canine Malassezia dermatitis. Can Vet J 58: 1119-1121.
Bajwa J (2023) Malassezia species and its significance in canine skin disease. Can Vet J 64: 87-90.
Bismarck D, Dusold A, Heusinger A, Müller E (2020) Antifungal in vitro activity of essential oils against clinical isolates of Malassezia pachydermatis from canine ears: a report from a practice laboratory. Complement Med Res 27: 143-154.
Boekhout T, Guého-Kellermann E, Mayser P, Velegraki A (2010) Malassezia and the skin: science and clinical practice. Springer Science & Business Media
Bohmova E, Conkova E, Harcarova M, Sihelska Z (2019) Interactions between Clotrimazole and selected essential oils against Malassezia pachydermatis clinical isolates. Pol J Vet Sci: 173-175.
Bond R, Elwood CM, Littler RM, Pinter L, Lloyd DH (1998) Humoral and cell-mediated responses to Malassezia pachydermatis in healthy dogs and dogs with Malassezia dermatitis. Vet Rec 143: 381-384.
Bond R, Lloyd DH (1997) Skin and mucosal populations of Malassezia pachydermatis in healthy and seborrhoeic Basset Hounds. Vet Dermatol 8: 101-106.
Bond R, Morris DO, Guillot J, Bensignor EJ, Robson D, Mason KV, Kano R, Hill PB (2020) Biology, diagnosis and treatment of Malassezia dermatitis in dogs and cats – Clinical consensus guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 31: 73-77.
Bond R, Patterson-Kane JC, Lloyd DH (2004) Clinical, histopathological and immunological effects of exposure of canine skin to Malassezia pachydermatis. Med Mycol 42: 165-175.
Breierová E, Kocková-Kratochvílová A, Šajbidor J, Ladzianská K (1991) Malassezia pachydermatis: properties and storage. Mycoses 34: 349-352.
Cabañes FJ, Coutinho SD, Puig L, Bragulat MR, Castellá G (2016) New lipid-dependent Malassezia species from parrots. Rev Iberoam Micol 33: 92-99.
Cafarchia C, Figueredo LA, Iatta R, Montagna MT, Otranto D (2012) In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions. Vet Microbiol 155: 395-398.
Cafarchia C, Gasser RB, Latrofa MS, Parisi A, Campbell BE, Otranto D (2008) Genetic variants of Malassezia pachydermatis from canine skin: body distribution and phospholipase activity. FEMS Yeast Res 8: 451-459.
Cafarchia C, Iatta R, Immediato D, Puttilli MR, Otranto D (2015) Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values. Med Mycol 53: 743-748.
Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22: 291-321.
Castellá G, Coutinho SDA, Cabañes FJ (2014) Phylogenetic relationships of Malassezia species based on multilocus sequence analysis. Med Mycol 52: 99-105.
Chen TA, Hill PB (2005) The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet Dermatol 16: 4-26.
Colombo S, Nardoni S, Cornegliani L, Mancianti F (2007) Prevalence of Malassezia spp. yeasts in feline nail folds: a cytological and mycological study. Vet Dermatol 18: 278-283.
Čonková E, Proškovcová M, Váczi P, Malinovská Z (2022) In vitro biofilm formation by Malassezia pachydermatis isolates and its susceptibility to azole antifungals. J Fungi (Basel) 8: 1209.
Čonková E, Váczi P, Malinovská Z (2025) Antifungal efficacy of selected plant essential oils against clinical canine isolates Malassezia pachydermatis. Microorganisms 13: 2675.
de Sousa DP, Damasceno RO, Amorati R, Elshabrawy HA, de Castro RD, Bezerra DP, Nunes VR, Gomes RC, Lima TC (2023) Essential oils: chemistry and pharmacological activities. Biomolecules 13:1144.
Dhifi W, Bellili S, Jazi S, Bahloul N, Mnif W (2016) Essential Oils’ Chemical Characterization and Investigation of Some Biological Activities: A Critical Review. Medicines (Basel) 3: 25.
Díaz L, Castellá G, Bragulat MR, Cabañes FJ (2023) ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis. Mycopathologia 188: 21-34.
Dinkova V, Rusenova N (2024) A retrospective study (2019-2023) on the prevalence and antimicrobial resistance of isolates from canine clinical samples submitted to the University Veterinary Hospital in Stara Zagora, Bulgaria. Microorganisms 12: 1670
Domán M, Első D, Pintér K, Wehmann E, Fehér E, Magyar T (2025) Antifungal susceptibility of Malassezia pachydermatis isolates from companion animals and genomic insights into resistance mechanisms. Antibiotics (Basel) 14: 902.
Faergemann J, Bernander S (1981) Micro-aerophilic and anaerobic growth of Pityrosporum species. Sabouraudia 19: 117-121.
Figueredo LA, Cafarchia C, Otranto D (2013) Antifungal susceptibility of Malassezia pachydermatis biofilm. Med Mycol 51: 863-867.
Galvis-Marín JC, Celis-Ramírez AM, Tabares-Villa FA, Zuluaga-Vélez A, Sepúlveda-Arias JC (2025) Characterisation of antifungal resistance to azoles in Colombian isolates of Malassezia spp. Mycoses 68: e70112.
Gomes RF, Mace MA, Loreto ÉS, Fuentefria AM, Zanette RA (2024) Alternative approaches for treating canine otitis externa caused by Malassezia pachydermatis: review and recommendations. Pubvet 18: e1544.
Guillot J, Bond R (1999) Malassezia pachydermatis: a review. Med Mycol 37: 295-306.
Guillot J, Guého E, Chévrier G, Chermette R (1997) Epidemiological analysis of Malassezia pachydermatis isolates by partial sequencing of the large subunit ribosomal RNA. Res Vet Sci 62: 22-25.
Gupta AK, Kohli Y, Summerbell RC (2000) Molecular differentiation of seven Malassezia species. J Clin Microbiol 38: 1869-1875.
Hammer KA, Carson CF, Riley TV (2004) Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 53: 1081-1085.
Hobi S, Cafarchia C, Romano V, Barrs VR (2022) Malassezia: zoonotic implications, parallels and differences in colonization and disease in humans and animals. J Fungi (Basel) 8: 708.
Honnavar P, Prasad GS, Ghosh A, Dogra S, Handa S, Rudramurthy SM (2016) Malassezia arunalokei sp. nov., a novel yeast species isolated from seborrheic dermatitis patients and healthy individuals from India. J Clin Microbiol 54: 1826-1834.
Hossain CM, Ryan LK, Gera M, Choudhuri S, Lyle N, Ali KA, Diamond G (2022) Antifungals and drug resistance. Encyclopedia 2: 1722-1737.
Hossain H, Landgraf V, Weiss R, Mann M, Hayatpour J, Chakraborty T, Mayser P (2007) Genetic and biochemical characterization of Malassezia pachydermatis with particular attention to pigment-producing subgroups. Med Mycol 45: 41-49.
Houšť J, Spížek J, Havlíček V (2020) Antifungal Drugs. Metabolites 10: 106.
Iatta R, Puttilli MR, Immediato D, Otranto D, Cafarchia C (2017) The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles. Mycoses 60: 178-182.
Jesus FP, Lautert C, Zanette RA, Mahl DL, Azevedo MI, Machado MLS, Dutra V, Botton SA, Alves SH, Santurio JM (2011) In vitro susceptibility of fluconazole-susceptible and resistant isolates of Malassezia pachydermatis against azoles. Vet Microbiol 152: 161-164.
Juhola J, Brennan E, Ferguson EA, Loeffler A, Hendricks A, Frosini SM, Chang YM, Bond R (2025) Fungal dysbiosis following antibacterial monotherapy in canine otitis externa. J Small Anim Pract 66: 149-157.
Kennis RA, Rosser EJ Jr, Olivier NB, Walker RW (1996) Quantity and distribution of Malassezia organisms on the skin of clinically normal dogs. J Am Vet Med Assoc 208: 1048-1051.
Kim M, Cho YJ, Park M, Choi Y, Hwang SY, Jung WH (2018) Genomic Tandem Quadruplication is Associated with Ketoconazole Resistance in Malassezia pachydermatis. J Microbiol Biotechnol 28: 1937-1945.
Kiss G, Radványi S, Szigeti G (1996) Characteristics of Malassezia pachydermatis strains isolated from canine otitis externa. Mycoses 39: 313-321.
Kolecka A, Khayhan K, Arabatzis M, Velegraki A, Kostrzewa M, Andersson A, Scheynius A, Cafarchia C, Iatta R, Montagna MT, Youngchim S, Cabañes FJ, Hoopman P, Kraak B, Groenewald M, Boekhout T (2014) Efficient identification of Malassezia yeasts by matrix‐
assisted laser desorption ionization‐time of flight mass spectrometry (MALDI‐TOF MS). Br J Dermatol 170: 332-341.
Lee TH, Hyun JE, Kang YH, Baek SJ, Hwang CY (2022) In vitro antifungal activity of cold atmospheric microwave plasma and synergistic activity against Malassezia pachydermatis when combined with chlorhexidine gluconate. Vet Med Sci 8: 524-529.
Lee Y, Robbins N, Cowen LE (2023) Molecular mechanisms governing antifungal drug resistance. NPJ Antimicrob Resist 1: 5.
Mauldin EA, Morris DO, Goldschmidt MH (2002) Retrospective study: the presence of Malassezia in feline skin biopsies. A clinicopathological study. Vet Dermatol 13: 7-14.
Mauldin EA, Scott DW, Miller WH, Smith CA (1997) Malassezia dermatitis in the dog: a retrospective histopathological and immunopathological study of 86 cases (1990-95). Vet Dermatol 8: 191-202.
Murayama N, Kano R (2023) Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan. J Vet Med Sci 85: 383-385.
Nardoni S, Mugnaini L, Pistelli L, Leonardi M, Sanna V, Perrucci S, Pisseri F, Mancianti F (2014) Clinical and mycological evaluation of an herbal antifungal formulation in canine Malassezia dermatitis. J Mycol Med 24: 234-240.
Nardoni S, Pistelli L, Baronti I, Najar B, Pisseri F, Bandeira Reidel RV, Papini R, Perrucci S, Mancianti F (2017) Traditional Mediterranean plants: characterization and use of an essential oils mixture to treat Malassezia otitis externa in atopic dogs. Nat Prod Res 31: 1891-1894.
Nazzaro F, Fratianni F, Coppola R, Feo V (2017) Essential oils and antifungal activity. Pharmaceuticals (Basel) 10: 86.
Nojo H, Murayama N, Ishijima SA, Kano R (2025) In vitro susceptibility testing of essential oils and their main components against antifungal-resistant Malassezia pachydermatis. J Vet Med Sci 87: 135-137.
Nolitt D, Drake E (2025) Suppurative Malassezia otitis externa: clinical features, treatment, and preliminary isolate identification. Vet Dermatol 36: 889-902.
Nunes Rodrigues TC, Vandenabeele SI (2021) Pilot study of dogs with suppurative and non-suppurative Malassezia otitis: a case series. BMC Vet Res 17: 353.
Nuttall TJ, Halliwell RE (2001) Serum antibodies to Malassezia yeasts in canine atopic dermatitis. Vet Dermatol 12: 327-332.
Olivry T, Hill PB (2001) The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions. Vet Immunol Immunopathol 81: 305-309.
Olivry T, Moore PF, Affolter VK, Naydan DK (1996) Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis. Arch Dermatol Res 288: 579-585.
Peano A, Johnson E, Chiavassa E, Tizzani P, Guillot J, Pasquetti M (2020) Antifungal resistance regarding Malassezia pachydermatis: Where are we now? J Fungi (Basel) 6: 93.
Pistelli L, Mancianti F, Bertoli A, Cioni PL (2012) Antimycotic activity of some aromatic plants essential oils against canine isolates of Malassezia pachydermatis: an in vitro assay. Open Mycol J 6: 17-21.
Plant JD, Rosenkrantz WS, Griffin CE (1992) Factors associated with and prevalence of high Malassezia pachydermatis numbers on dog skin. J Am Vet Med Assoc 201: 879-882.
Puig L, Castellá G, Cabañes FJ (2016) Cryptic diversity of Malassezia pachydermatis from healthy and diseased domestic animals. Mycopathologia 181: 681-688.
Schlemmer KB, Jesus FP, Tondolo JS, Weiblen C, Azevedo MI, Machado VS, Botton SA, Alves SH, Santurio JM (2019) In vitro activity of carvacrol, cinnamaldehyde and thymol combined with antifungals against Malassezia pachydermatis. J Mycol Med 29: 375-377.
Scott DW, Miller WH (1989) Epidermal dysplasia and Malassezia pachydermatis infection in West Highland White Terriers. Vet Dermatol 1: 25-36.
Sim JX, Khazandi M, Pi H, Venter H, Trott DJ, Deo P (2019) Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens. J Appl Microbiol 127, 99-108.
Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE (2009) Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5: e1000532.
Teoh Z, Mortensen J, Schaffzin JK (2022) Invasive Malassezia pachydermatis infection in an 8-year-old child on lipid parenteral nutrition. Case Rep Infect Dis 2022: 8636582.
Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL Jr (2018) Malassezia ecology, pathophysiology, and treatment. Med Mycol 56: S10-S25.
Uchida Y, Onodera S, Nakade T, Otomo K (1994) Sterol composition in polyene antibiotic-sensitive and resistant strains of Malassezia pachydermatis. Vet Res Commun 18: 183-187.
Ushijima T, Takahashi M, Ozaki Y (1981) Selective and differential media for isolation and tentative identification of each species of pityrosporum residing on normal or diseased human skin. Microbiol Immunol 25: 1109-1118.
Váczi P, Čonková E, Malinovská Z (2024) Synergistic effect of essential oils and chlorhexidine against planktonic and biofilm-forming cells of Malassezia pachydermatis. Vet Anim Sci 26: 100397.
Váczi P, Čonková E, Marcinčáková D, Sihelská Z (2018) Antifungal effect of selected essential oils on Malassezia pachydermatis growth. Folia Vet 62: 67-72.
Wang QM, Theelen B, Groenewald M, Bai FY, Boekhout T (2014) Moniliellomycetes and Malasseziomycetes, two new classes in Ustilaginomycotina. Persoonia 33: 41-47.
Weiler CB, de Jesus FP, Nardi GH, Loreto ÉS, Santurio JM, Coutinho SD, Alves SH (2013) Susceptibility variation of Malassezia pachydermatis to antifungal agents according to isolate source. Braz J Microbiol 44: 175-178.
Wu G, Zhao H, Li C, Rajapakse MP, Wong WC, Xu J, Saunders CW, Reeder NL, Reilman RA, Scheynius A, Sun S, Billmyre BR, Li W, Averette AF, Mieczkowski P, Heitman J, Theelen B, Schröder MS, de Sessions PF, Butler G, Maurer-Stroh S, Boekhout T, Nagarajan N, Dawson TL Jr (2015) Genus-wide comparative genomics of Malassezia delineates its phylogeny, physiology, and niche adaptation on human skin. PLoS Genet 11: e1005614.
Yurayart C, Niae S, Limsivilai O, Thengchaisri N, Sattasathuchana P (2024) Comparative analysis of the distribution and antifungal susceptibility of yeast species in cat facial hair and human nails. Sci Rep 14: 14726.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Polish Journal of Veterinary Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
